Search Results - "Fogaca, Manoela V."

Refine Results
  1. 1

    Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions by Fogaça, Manoela V, Duman, Ronald S

    Published in Frontiers in cellular neuroscience (12-03-2019)
    “…Major depressive disorder (MDD) is a debilitating illness characterized by neuroanatomical and functional alterations in limbic structures, notably the…”
    Get full text
    Journal Article
  2. 2

    Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses by Fogaça, Manoela V, Daher, Fernanda, Picciotto, Marina R

    Published in Neuropsychopharmacology (New York, N.Y.) (11-10-2024)
    “…Major depressive disorder (MDD) is associated with disruptions in glutamatergic and GABAergic activity in the medial prefrontal cortex (mPFC), leading to…”
    Get full text
    Journal Article
  3. 3

    Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents by Ghosal, Sriparna, Duman, Catharine H., Liu, Rong-Jian, Wu, Min, Terwilliger, Rosemarie, Girgenti, Matthew J., Wohleb, Eric, Fogaca, Manoela V., Teichman, Emily M., Hare, Brendan, Duman, Ronald S.

    Published in Neurobiology of disease (01-02-2020)
    “…Dysfunction of medial prefrontal cortex (mPFC) in association with imbalance of inhibitory and excitatory neurotransmission has been implicated in depression…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function by Duman, Ronald S., Shinohara, Ryota, Fogaça, Manoela V., Hare, Brendan

    Published in Molecular psychiatry (01-12-2019)
    “…Efforts to develop efficacious antidepressant agents with novel mechanisms have been largely unsuccessful since the 1950’s until the discovery of ketamine, an…”
    Get full text
    Journal Article
  6. 6

    Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine by Fukumoto, Kenichi, Fogaça, Manoela V., Liu, Rong-Jian, Duman, Catharine, Kato, Taro, Li, Xiao-Yuan, Duman, Ronald S.

    “…Ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, produces rapid and long-lasting antidepressant effects in major depressive disorder…”
    Get full text
    Journal Article
  7. 7

    Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses by Fogaça, Manoela V., Wu, Min, Li, Chan, Li, Xiao-Yuan, Picciotto, Marina R., Duman, Ronald S.

    Published in Molecular psychiatry (01-07-2021)
    “…Major depressive disorder (MDD) is associated with alterations of GABAergic interneurons, notably somatostatin (Sst) as well as parvalbumin (Pvalb), in…”
    Get full text
    Journal Article
  8. 8

    The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling by Fogaça, Manoela V., Campos, Alline C., Coelho, Ludmila D., Duman, Ronald S., Guimarães, Francisco S.

    Published in Neuropharmacology (01-06-2018)
    “…Repeated injections of cannabidiol (CBD), the major non-psychotomimetic compound present in the Cannabis sativa plant, attenuate the anxiogenic effects induced…”
    Get full text
    Journal Article
  9. 9

    Cannabidiol, neuroprotection and neuropsychiatric disorders by Campos, Alline C., Fogaça, Manoela V., Sonego, Andreza B., Guimarães, Francisco S.

    Published in Pharmacological research (01-10-2016)
    “…[Display omitted] Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis sativa. It has possible therapeutic effects over a broad…”
    Get full text
    Journal Article
  10. 10

    N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects by Fogaça, Manoela V, Fukumoto, Kenichi, Franklin, Tina, Liu, Rong-Jian, Duman, Catharine H, Vitolo, Ottavio V, Duman, Ronald S

    Published in Neuropsychopharmacology (New York, N.Y.) (01-12-2019)
    “…Currently available antidepressants have a delayed onset and limited efficacy, highlighting the need for new, rapid and more efficacious agents. Ketamine, an…”
    Get full text
    Journal Article
  11. 11

    Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation by Fukumoto Kenichi, Fogaça Manoela V, Rong-Jian, Liu, Duman, Catharine H, Xiao-Yuan, Li, Chaki Shigeyuki, Duman, Ronald S

    Published in Neuropsychopharmacology (New York, N.Y.) (01-09-2020)
    “…We previously reported that the serotonergic system is important for the antidepressant-like effects of ketamine, a non-competitive N-methyl-D-aspartate…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex by Sales, Amanda J., Fogaça, Manoela V., Sartim, Ariandra G., Pereira, Vitor S., Wegener, Gregers, Guimarães, Francisco S., Joca, Sâmia R. L.

    Published in Molecular neurobiology (01-02-2019)
    “…Currently available antidepressants have a substantial time lag to induce therapeutic response and a relatively low efficacy. The development of drugs that…”
    Get full text
    Journal Article
  14. 14

    Animal models of anxiety disorders and stress by Campos, Alline C, Fogaça, Manoela V, Aguiar, Daniele C, Guimarães, Francisco S

    Published in Revista brasileira de psiquiatria (2013)
    “…Anxiety and stress-related disorders are severe psychiatric conditions that affect performance in daily tasks and represent a high cost to public health. The…”
    Get full text
    Journal Article
  15. 15

    Prefrontal cortex interneurons display dynamic sex-specific stress-induced transcriptomes by Girgenti, Matthew J., Wohleb, Eric S., Mehta, Sameet, Ghosal, Sriparna, Fogaca, Manoela V., Duman, Ronald S.

    Published in Translational psychiatry (11-11-2019)
    “…γ-aminobutyric acid (GABA) inhibitory interneurons play a key role in efferent and afferent control of principle neuron activity in the prefrontal cortex…”
    Get full text
    Journal Article
  16. 16

    M1 acetylcholine receptors in somatostatin interneurons contribute to GABAergic and glutamatergic plasticity in the mPFC and antidepressant-like responses by Fogaça, Manoela V, Wu, Min, Li, Chan, Li, Xiao-Yuan, Duman, Ronald S, Picciotto, Marina R

    Published in Neuropsychopharmacology (New York, N.Y.) (01-08-2023)
    “…Alterations in glutamatergic and GABAergic function in the medial prefrontal cortex (mPFC) are prevalent in individuals with major depressive disorder,…”
    Get full text
    Journal Article
  17. 17

    Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders by Campos, Alline C, Fogaça, Manoela V, Scarante, Franciele F, Joca, Sâmia R L, Sales, Amanda J, Gomes, Felipe V, Sonego, Andreza B, Rodrigues, Naielly S, Galve-Roperh, Ismael, Guimarães, Francisco S

    Published in Frontiers in pharmacology (23-05-2017)
    “…Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric disorders, including anxiety, psychosis, and depression. The…”
    Get full text
    Journal Article
  18. 18

    The synergistic mechanism of action of Dajianzhong decoction in conjunction with ketamine in the treatment of depression by Li, Chan, Zhang, Jiping, Liu, Hanhe, Yuan, Huijie, Cai, Jianxin, Fogaça, Manoela V., Zhang, Yuan-Wei

    Published in Biomedicine & pharmacotherapy (01-09-2023)
    “…Depression is a multifactorial syndrome with a variety of underlying pathological mechanisms. While ketamine, an N-methyl-D-aspartate receptor (NMDAR)…”
    Get full text
    Journal Article
  19. 19

    The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior by Fogaça, Manoela V., Aguiar, Daniele C., Moreira, Fabrício A., Guimarães, Francisco S.

    Published in Neuropharmacology (01-08-2012)
    “…Cannabinoid receptor 1 (CB1) agonists usually induce dose-dependent biphasic effects on anxiety-related responses. Low doses induce anxiolytic-like effects,…”
    Get full text
    Journal Article
  20. 20

    The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors by Batista, Priscila A., Fogaça, Manoela V., Guimarães, Francisco S.

    Published in Behavioural brain research (15-10-2015)
    “…•AEA induces biphasic effects in the modulation of anxiety-like behaviors in the dlPAG.•AEA induces an anxiolytic-like effect in the dlPAG at lower doses.•The…”
    Get full text
    Journal Article